---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-131855"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:20:57.542514+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inogen names Jason Richardson CFO, appoints CMO and VP Sales; reaffirms 2026 guidance

## Summary
- Jason Richardson appointed CFO effective April 6, 2026; previously CFO of Baxter's Health System & Technologies segment.
- Michael Bourque steps down as CFO on April 6, remains Senior Advisor through June 30, 2026.
- Dominic Hulton appointed CMO effective April 1, 2026; previously VP International Marketing at Insulet.
- Corey Moritz appointed VP U.S. Business to Business Sales, started March 9; formerly CCO at Rhythm Healthcare.
- Company reaffirms Q1 and full year 2026 financial outlook provided on February 24, 2026.

## SEC filing metadata
- accession: 0001193125-26-131855
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000119312526131855/0001193125-26-131855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000119312526131855/ingn-20260324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-131855
- JSON: https://secwatch.observer/filing/0001193125-26-131855.json
- Plain text: https://secwatch.observer/filing/0001193125-26-131855.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.